Cargando…
Sarcopenia and Frailty in Heart Failure: Is There a Biomarker Signature?
PURPOSE OF REVIEW: Sarcopenia and frailty are common in patients with heart failure (HF) and are strongly associated with prognosis. This review aims to examine promising biomarkers that can guide physicians in identifying sarcopenia and frailty in HF. RECENT FINDINGS: Traditional biomarkers includi...
Autores principales: | Sato, Ryosuke, Vatic, Mirela, da Fonseca, Guilherme Wesley Peixoto, von Haehling, Stephan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653351/ https://www.ncbi.nlm.nih.gov/pubmed/36261756 http://dx.doi.org/10.1007/s11897-022-00575-w |
Ejemplares similares
-
Biomarkers of Cardiac Stress and Cytokine Release Syndrome in COVID-19: A Review
por: Gordon, Jonathan S., et al.
Publicado: (2021) -
Biomarker-Based Assessment for Infectious Risk Before and After Heart Transplantation
por: Huang, Athena L., et al.
Publicado: (2022) -
Biomarkers for Myocarditis and Inflammatory Cardiomyopathy
por: Suresh, Abhilash, et al.
Publicado: (2022) -
New Approaches to Donor Selection and Preparation in Heart Transplantation
por: Tong, Calvin K. W., et al.
Publicado: (2021) -
A Critical Review of Hemodynamically Guided Therapy for Cardiogenic Shock: Old Habits Die Hard
por: Isseh, Iyad N., et al.
Publicado: (2021)